Kwality Pharmaceuticals Ltd — Important, 12-02-2026: Company Update

Kwality Pharmaceuticals reported strong financial results for the quarter and nine-month period ending FY26. For Q3 FY26, revenue increased 46.2% year-on-year to INR 123 Cr, with profit after tax rising 87.8% to INR 16 Cr. For the nine-month period, revenue grew 35.9% to INR 346 Cr, and profit after tax surged 66.0% to INR 42 Cr. Key drivers include new product registrations, market entries into regulated regions like Mexico and South Africa, successful regulatory audits, progress in bioequivalence programs, and ongoing expansion in biologics and oncology capacities, with a new hormone facility under construction.